SHPH
Shuttle Pharmaceuticals Inc
NASDAQ: SHPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.00
-4.76% today
Updated 2026-04-29
Market cap
$5.76M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-7.16
Dividend yield
—
52W range
$1 – $8
Volume
0.2M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-973012.00
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-5.00M | $-6.59M | $-9.14M | $-11.72M | $-2.61M |
| EPS | — | — | — | — | $-7.16 |
| Free cash flow | $-2.71M | $-5.60M | $-7.35M | $-9.48M | $-973012.00 |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Shuttle Pharmaceuticals Inc trades at $1.00. Our Smart Value Score of 21/100 indicates the stock is weak.
Frequently asked questions
What is Shuttle Pharmaceuticals Inc's stock price?
Shuttle Pharmaceuticals Inc (SHPH) trades at $1.00.
Is Shuttle Pharmaceuticals Inc overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell).
What is the price target of Shuttle Pharmaceuticals Inc (SHPH)?
The analyst target price is $—, representing NaN% downside from the current price of $1.00.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-791.00%
Beta0.72
50D MA$0.92
200D MA$2.38
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—